AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / PHARMACEUTICAL PREPARATIONS
CDT Equity Inc. Common Stock
XNAS · usd
SIC 2834 · PHARMACEUTICAL PREPARATIONS
FIGI BBG015879NG6
0.13▼ 0.00 (-0.08%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
Trailing P/E
—
Price / Sales
—
EV / Revenue
—
EV / EBITDA
—
Financial Highlights
Revenue (TTM)
—
Net Income (TTM)
EBITDA
—
Diluted EPS (TTM)
EBITDA Margin
—
Net Debt
Trading Information
Previous Close
0.13
Day's Range
0.12 – 0.17
52-Week Range
0.07 – 11.00
Volume
5.8M
Avg Volume
5.8M
Share Statistics
Shares Outstanding
Employees
4
Exchange
XNAS
Listed
2023-09-25
Share count as of August 12, 2026

CDT Equity Inc. Common Stock (CDT) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about CDT Equity Inc. Common Stock (CDT)
What is CDT Equity Inc. Common Stock's Market Cap?
CDT Equity Inc. Common Stock's Market Cap is $102.3K, based on as-reported figures from SEC (XBRL) filings.
What is CDT Equity Inc. Common Stock's Enterprise Value?
CDT Equity Inc. Common Stock's Enterprise Value is -$644.7K, based on as-reported figures from SEC (XBRL) filings.
What is CDT Equity Inc. Common Stock's Net Income (TTM)?
CDT Equity Inc. Common Stock's Net Income (TTM) is -$37.1M, based on as-reported figures from SEC (XBRL) filings.
What is CDT Equity Inc. Common Stock's Diluted EPS (TTM)?
CDT Equity Inc. Common Stock's Diluted EPS (TTM) is -47.22, based on as-reported figures from SEC (XBRL) filings.
What is CDT Equity Inc. Common Stock's Net Debt?
CDT Equity Inc. Common Stock's Net Debt is -$747.0K, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · CDTAs-filed SEC (XBRL) data
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Operating expenses:
Research and Development Expense
Selling, General and Administrative Expense
Total operating expenses
Operating loss
Other income (expense):
Other expense, net——
Gain/Loss on Investments——
Non-Operating Income (Expense)——
Interest Expense
Total other expense, net
Net loss
Earnings Per Share (Basic)—
Earnings Per Share (Diluted)—